The GLP-1 conversation comes loaded with terminology — some of it medical, some of it pharmacological, some of it nutritional. Encountering an unfamiliar term mid-article and having to stop to look it up breaks the flow of learning and, frankly, gets old quickly. This glossary collects the key terms you’ll encounter across this site and in the broader GLP-1 conversation, explains each one in plain language, and gives enough context to make the definition genuinely useful rather than technically correct but practically empty. Bookmark this page. You’ll likely want to refer back to it.
Core GLP-1 and Hormone Terms
These are the foundational terms that appear in almost every GLP-1 article. Getting them clear first makes everything else easier to follow.
GLP-1 (Glucagon-Like Peptide-1)
A hormone produced naturally by specialized cells in your small intestine and colon, released in response to eating. GLP-1 tells your pancreas to release insulin when blood sugar is elevated, suppresses glucagon to prevent excess liver glucose release, slows digestion to flatten post-meal blood sugar spikes, and signals your brain that you’re full. It’s broken down by an enzyme called DPP-4 within one to two minutes of release. The full explanation is in What Is GLP-1 and Why Does It Matter?
GLP-1 Receptor Agonist
A prescription drug that mimics GLP-1 by binding to and activating the same receptors, but is engineered to resist the DPP-4 breakdown that clears natural GLP-1 within minutes. GLP-1 receptor agonists like semaglutide remain active for days, producing sustained appetite suppression, blood sugar regulation, and weight loss that natural GLP-1 pulses cannot match in magnitude. Ozempic, Wegovy, and Mounjaro are GLP-1 receptor agonists. See The Difference Between GLP-1 and GLP-1 Receptor Agonists.
Incretin
A class of gut hormones released after eating that stimulate insulin secretion from the pancreas. GLP-1 is the most studied incretin. The other major incretin is GIP (glucose-dependent insulinotropic polypeptide). Incretins are responsible for the incretin effect — the observation that eating food triggers more insulin release than infusing equivalent glucose directly into the bloodstream. In type 2 diabetes, the incretin effect is significantly reduced.
Incretin Effect
The amplification of insulin release that occurs when food is eaten compared to when equivalent glucose is delivered intravenously. The gut senses incoming nutrients and sends hormonal signals — primarily GLP-1 — to prime the pancreas before blood sugar even begins to rise significantly. This effect accounts for roughly 50 to 70% of the post-meal insulin response in healthy individuals and is markedly blunted in type 2 diabetes.
Insulin
A hormone produced by the pancreas’s beta cells that signals cells throughout the body to absorb glucose from the bloodstream for energy. Insulin is the primary regulator of blood sugar after meals. GLP-1 is one of its most important upstream stimulators — when GLP-1 rises after eating, it prompts the pancreas to release more insulin, but only when blood sugar is actually elevated. See GLP-1 and Insulin: How They Work Together.
Glucagon
A hormone produced by the pancreas’s alpha cells that signals the liver to release stored glucose into the bloodstream — the opposite action of insulin. Glucagon is suppressed by GLP-1 after meals, preventing the liver from adding more glucose to an already-rising system. In type 2 diabetes, this glucagon suppression is often impaired, contributing to elevated post-meal blood sugar.
Insulin Resistance
A condition in which cells become less responsive to insulin’s signal to absorb glucose. The pancreas compensates by producing more insulin, but over time struggles to keep up, leading to elevated blood sugar. Insulin resistance is the central feature of type 2 diabetes and metabolic syndrome, and it is associated with reduced GLP-1 output — a self-reinforcing cycle that natural GLP-1 support can help interrupt.
Semaglutide
The active ingredient in Ozempic (approved for type 2 diabetes), Wegovy (approved for weight management), and Rybelsus (oral tablet for type 2 diabetes). Semaglutide is a GLP-1 receptor agonist engineered to resist DPP-4 breakdown and remain active for approximately one week after a single injection. It is currently the most widely discussed and prescribed GLP-1 drug. See What Is Semaglutide and How Does It Work?
Tirzepatide
The active ingredient in Mounjaro (type 2 diabetes) and Zepbound (weight management). Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both the GLP-1 receptor and the GIP receptor simultaneously. Clinical trials have shown even larger weight loss results with tirzepatide than with semaglutide, likely because of this dual receptor activation.
Cellular and Biological Terms
These terms describe the biological machinery behind GLP-1 production and action. They appear regularly in the more mechanistic articles on this site.
L-Cell
The specialized hormone-producing cell in the lining of the small intestine and colon that manufactures and releases GLP-1. L-cells are a type of enteroendocrine cell and are most densely concentrated in the ileum and colon. They sense nutrients — particularly fats, proteins, and the short-chain fatty acids produced by gut bacteria — and release GLP-1 in response. See The Role of the L-Cell in GLP-1 Production.
Beta Cell
The insulin-producing cells of the pancreas. GLP-1 binds to receptors on beta cells to stimulate insulin release after meals, but only when blood sugar is elevated. Beta cells are progressively damaged in type 2 diabetes, reducing the pancreas’s capacity to produce adequate insulin. GLP-1 receptor activation may support beta cell survival and function, though the evidence in humans is still developing.
Alpha Cell
The glucagon-producing cells of the pancreas. GLP-1 suppresses alpha cell glucagon release after meals, preventing the liver from releasing additional glucose into the bloodstream when blood sugar is already rising. Impaired alpha cell suppression is a feature of type 2 diabetes that contributes to post-meal blood sugar elevation.
DPP-4 (Dipeptidyl Peptidase-4)
The enzyme that breaks down natural GLP-1 in the bloodstream, typically within one to two minutes of release. DPP-4’s rapid clearance of GLP-1 is why natural GLP-1 acts as a brief pulse rather than a sustained signal. Pharmaceutical DPP-4 inhibitors (gliptins) slow this breakdown to extend the window of GLP-1 activity. Some natural compounds, including EGCG from green tea extract, have shown mild DPP-4-inhibiting activity in research.
AMPK (AMP-Activated Protein Kinase)
A cellular energy-sensing enzyme that plays a central role in metabolic regulation. When activated, AMPK improves glucose uptake, enhances insulin sensitivity, and supports fat burning. Berberine activates AMPK, which is one of its primary mechanisms for improving blood sugar control — separate from but complementary to its GLP-1-stimulating effects.
Short-Chain Fatty Acids (SCFAs)
Small molecules — primarily butyrate, propionate, and acetate — produced when gut bacteria ferment dietary fiber in the colon. SCFAs directly stimulate L-cells to release GLP-1, making them a crucial link in the chain between dietary fiber, gut microbiome health, and GLP-1 output. They also support gut barrier integrity and have anti-inflammatory effects. Low-fiber diets reduce SCFA production and consequently weaken GLP-1 stimulation.
Gastric Emptying
The rate at which food moves from the stomach into the small intestine. GLP-1 slows gastric emptying, which extends the physical sensation of fullness after meals and reduces the rate at which glucose enters the bloodstream — flattening the post-meal blood sugar curve. This is one of GLP-1’s three primary mechanisms for blood sugar regulation, alongside insulin stimulation and glucagon suppression.
Enteroendocrine Cell
Any hormone-producing cell embedded in the lining of the digestive tract. The gut contains several types of enteroendocrine cells, each producing different hormones. L-cells are one type. Others produce hormones like cholecystokinin (CCK), which signals satiety and stimulates digestive enzyme release, and ghrelin, the hunger hormone. The gut’s endocrine function is far more extensive than most people realize.
Supplement and Nutrition Terms
These terms come up frequently in the supplements and diet sections of this site.
Berberine
A plant-derived alkaloid found in plants including goldenseal, barberry, and Oregon grape. Berberine is the most clinically studied natural supplement for GLP-1 support and metabolic health. It activates AMPK, stimulates GLP-1 secretion from L-cells, and has shown meaningful blood sugar and modest weight loss effects in human trials. See Berberine and GLP-1: What the Research Actually Shows.
EGCG (Epigallocatechin Gallate)
The primary bioactive catechin in green tea extract. EGCG has shown mild DPP-4 inhibiting activity in research — potentially slowing GLP-1 breakdown — along with antioxidant and insulin-sensitizing effects. It is among the more promising natural GLP-1-supporting compounds, though human evidence for its GLP-1 effects is less robust than for berberine or dietary fiber.
Psyllium Husk
A concentrated source of soluble fiber derived from the seeds of Plantago ovata. Psyllium is one of the most practical supplement options for supporting GLP-1 through the fiber-SCFA pathway. It slows digestion, feeds fiber-fermenting gut bacteria, supports post-meal blood sugar stability, and promotes satiety. Available in powder or capsule form and easy to incorporate daily.
Prebiotics
Non-digestible food components — primarily certain types of fiber — that selectively feed beneficial gut bacteria. Prebiotic fibers include inulin, fructooligosaccharides (FOS), and resistant starch. They support the SCFA-producing bacteria that drive GLP-1 stimulation. Prebiotic foods include garlic, onions, leeks, asparagus, oats, and green bananas.
Probiotics
Live microorganisms — primarily bacteria — that, when consumed in adequate amounts, confer a health benefit on the host. In the GLP-1 context, probiotic strains from the Lactobacillus and Bifidobacterium genera have shown metabolic health benefits in research, likely partly through supporting the microbiome environment that drives GLP-1 secretion. Effects are strain-specific and work best alongside adequate prebiotic fiber.
Resistant Starch
A type of starch that resists digestion in the small intestine and passes intact to the colon, where gut bacteria ferment it into SCFAs. Resistant starch is found in green bananas, cooked-and-cooled rice and potatoes, legumes, and some whole grains. It is among the most effective prebiotic substrates for SCFA production and therefore GLP-1 stimulation.
HbA1c (Hemoglobin A1c)
A blood test that reflects average blood sugar levels over the preceding two to three months by measuring the percentage of hemoglobin with glucose attached. HbA1c is the standard clinical measure for monitoring blood sugar control in diabetes management. A reduction in HbA1c is a key outcome measure in studies of both prescription GLP-1 drugs and natural supplements like berberine.
Visceral Fat
Fat stored around the abdominal organs, as opposed to subcutaneous fat stored just under the skin. Visceral fat is metabolically active in ways that impair insulin sensitivity and GLP-1 function, and it is strongly associated with cardiovascular risk and type 2 diabetes. GLP-1-based interventions — both prescription and natural — tend to preferentially reduce visceral fat relative to overall body fat.
Using This Glossary Alongside the Site
The terms defined here will appear throughout the articles on Best GLP1 Supplements, typically explained briefly on first use within each article. This glossary is designed as a reference you can return to whenever a term needs a fuller explanation than the inline definition provides.
If you’re new to the topic and want a logical reading sequence, the GLP-1 Basics category articles are designed to build understanding progressively — starting with What Is GLP-1 and Why Does It Matter? and working through to the more specific mechanistic articles. If you’re ready to move directly to supplements, Berberine and GLP-1: What the Research Actually Shows is the most evidence-rich starting point.